NEW YORK (GenomeWeb News) – Keygene has licensed its DNA marker technology to the Belgium Institute for Agricultural and Fisheries Research, or ILVO, the Dutch company said today.
Under the limited, non-exclusive agreement, ILVO will use Keygene’s AFLP technology to perform reactions to identify certain plant varieties.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.